Feb 28, 2019

Philips debuts expanded precision diagnosis and image guided therapy portfolio at ECR 2019

New Incisive CT helps healthcare organizations meet their most pressing financial, clinical and operational goals
EMEA introduction of Illumeo with adaptive intelligence set to change how clinicians see, seek and share information
Azurion with FlexArm opens up new imaging and patient positioning opportunities for image guided procedures

Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today debuted an expanded portfolio of solutions that advance precision diagnosis and image guided therapies at the 2019 European Congress of Radiology. At the congress, Philips unveiled the Incisive CT system, which integrates innovations in imaging, workflow and lifecycle management to help healthcare organizations achieve their financial, clinical and operational goals. The company also announced the availability of Illumeo with adaptive intelligence in markets across EMEA [1]. Available as part of Philips’ IntelliSpace informatics portfolio, Illumeo sets a new paradigm of clinically intelligent software designed to change how clinicians see, seek and share information by providing a tailored workflow experience which adapts to their preferences and the patient context.

At this year’s ECR we’re debuting an expanded portfolio across precision diagnosis and image guided therapy that supports clinicians in getting the right treatment to the right patient at the right time.

Robert Cascella

Chief Business Leader Precision Diagnosis, Philips

“The diagnosis and treatment of disease is becoming increasingly precise, combining data from a wide range of sources and applying intelligence to that data to provide personalized healthcare that’s based on a deep understanding of the individual patient,” said Robert Cascella, Chief Business Leader Precision Diagnosis, Philips. “At this year’s ECR we’re debuting an expanded portfolio across precision diagnosis and image guided therapy that supports clinicians in getting the right treatment to the right patient at the right time.”

Advancing value-based care in CT

The newest addition to Philips’ diagnostic imaging portfolio, Incisive CT integrates innovations in imaging, workflow, and lifecycle management, helping healthcare providers to improve the CT experience for patients and staff, enable smart clinical decision-making and increase efficiency. With its industry-first ‘Tube for Life’ guarantee [2], Philips will replace the Incisive’s X-ray tube – a key component of any CT system – at no additional cost throughout the entire life of the system, potentially lowering operating expenses by an estimated $400,000 [3]. Incisive CT will be introduced in major markets in Europe and Asia in the first half of 2019, and will subsequently be rolled out in further markets [4].

At the congress Philips is also showcasing its recently-introduced Azurion with FlexArm system, setting a new standard for patient imaging and positioning flexibility for image-guided procedures. During increasingly complex interventions, clinicians need to quickly and easily visualize critical anatomy and identify changes to the patient during the procedure. Azurion with FlexArm includes a set of innovations that makes it easier for the clinician to perform imaging across the whole patient in both 2D and 3D. As the clinician moves the system, the image beam automatically maintains alignment with the patient, allowing more consistent visualization and enabling them to keep their focus on the treatment.

Philips is also showcasing the EPIQ Elite ultrasound system, a new premium ultrasound that combines the latest advances in transducer innovation and enhanced performance to improve clinical confidence and the patient experience. EPIQ Elite offers a range of diagnostic ultrasound solutions tailored to the needs of specific medical specialties, including Philips’ first solution for vascular assessment and diagnosis. In addition, EPIQ Elite for Obstetrics & Gynecology delivers extraordinary image quality and lifelike 3D scans to provide advanced fetal assessment during all stages of pregnancy.

At ECR 2019 Philips is showcasing IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced visualization and quantification software. Philips IntelliSpace Portal is an advanced visualization and analysis software designed to support diagnostic process, follow-up and communication across clinical domains and modalities, through a connected and secure workflow. The new version further extends the clinical innovation of the Portal, with enhancements to improve workflow efficiencies, bridging secure data sharing between within the hospital network to address the security and privacy needs of customers globally.

Philips is also showcasing its latest advances in its Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that break down diagnostic boundaries by delivering speed, comfort and confidence, all with the aim to help improve patient care. The company will also highlight a recent study that demonstrates how a more patient-focused approach to managing patient stress and motion can result in MRI productivity gains [5].

Visit Philips at the 2019 European Congress of Radiology (ECR) Exhibition (February 28 – March 3, 2019, Vienna, Austria) on Booth 402, Hall X4. You can also follow @PhilipsLiveFrom for live #ECR2019 updates.

[1] Illumeo with adaptive intelligence is now available most major markets in the EU and the Middle East and in South Africa.

[2] Life of the product is defined by Philips as 10 years. Tube for Life guarantee availability varies by country. Please contact your local Philips sales representative for details.

[3] Actual operating costs for customers vary significantly because many variables exist (such as CT make and model, hospital/imaging center size, case mix, system usage). The potential savings identified estimates the avoidance of purchasing replacement tubes over a 10-year useful life of a CT system, based on an average selling price of $140,000 per replacement tube and estimated tube life of 3 years. There can be no guarantee that all customers will achieve this result. Tube for Life guarantee availability varies by country.

[4] The Incisive CT is not available for sale in North America.

[5] “Realizing productivity gains during MRI scans”, whitepaper published by Philips, Nov 2018.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.